Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
KINE-101A by Kine Sciences for Rheumatoid Arthritis: Likelihood of Approval
KINE-101A is under clinical development by Kine Sciences and currently in Phase I for Rheumatoid Arthritis. According to GlobalData, Phase...